2000–2010 to 2011–2022 saw increase in lifetime risk for atrial fibrillation
From 2000 to 2022, there was an increase in the lifetime risk for atrial fibrillation, according to a study published online April 17 in The BMJ.
Apr 22, 2024
0
0
From 2000 to 2022, there was an increase in the lifetime risk for atrial fibrillation, according to a study published online April 17 in The BMJ.
Apr 22, 2024
0
0
Collaborative research, led from the University of Oxford and published today in Nature Medicine, has developed a new tool called QR4 that more accurately predicts an individual's 10-year risk of cardiovascular diseases, ...
Apr 18, 2024
0
57
The lifetime risk of atrial fibrillation (a heart condition that causes an irregular and often abnormally fast heart rate) has increased from one in four to one in three over the past two decades, finds a study from Denmark ...
Apr 17, 2024
0
134
Health care providers who are working with adult patients struggling to stop smoking should consider discussing e-cigarettes as a potential tool if they've already tried FDA-approved medications, say tobacco researchers with ...
Apr 16, 2024
0
0
In the wake of the COVID-19 pandemic, many families worried about the long-term effects posed by the SARS-COV-2 virus. Now, researchers from Children's Hospital of Philadelphia (CHOP) found that a SARS-COV-2 infection likely ...
Apr 12, 2024
0
1
The concept of One Health—which emphasizes the relationship between human, animal, plant and environmental health—has been gaining ground in scientific discussions in recent years. Brazilian and North American researchers ...
Apr 11, 2024
0
1
Artificial intelligence will significantly impact the heart transplantation process by helping physicians better assess the complex factors impacting patient outcomes, according to researchers at today's Annual Meeting and ...
Apr 10, 2024
0
0
In patients with device-detected atrial fibrillation and a high comorbidity burden, oral anticoagulation increases bleeding without a clear reduction in stroke. This is the main finding of a sub-analysis of the NOAH–AFNET ...
Apr 9, 2024
0
1
Among patients at high or very high risk for a heart attack or stroke, the addition of the investigational drug lerodalcibep to standard cholesterol-lowering medication for one year reduced LDL, or "bad" cholesterol, levels ...
Apr 8, 2024
0
0
Withdrawing aspirin one month after percutaneous coronary intervention (PCI) in high-risk heart patients and keeping them on ticagrelor alone safely improves outcomes and reduces major bleeding by more than half when compared ...
Apr 7, 2024
0
55